NIPH Clinical Trials Search

UMIN ID: C000000428

Registered date:09/06/2006


Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedChronic heart failure
Date of first enrollment2006/06/01
Target sample size470
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Pitavastatin group Control group


Primary OutcomeCardiac death or hospitalization due to worsening CHF.
Secondary OutcomeTotal mortality Cardiac death Hospitalization due to worsening CHF Acute myocardial infarction or unstable angina pectoris Cerebral stroke Undergo percutaneous coronary intervention Surgical therapy for worsening CHF Composite of above

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum80years-old
GenderMale and Female
Include criteria
Exclude criteria1) Patients who had already treated with statin. 2)Patients who will undertake changes of alternative treatment of CHF. 3) Myocardial infarction occurred within three months. 4) CABG or PCI performed within three months, or planning them. 5) Patients with active malignant tumor. 6) Patients with severe renal and hepatic dysfunction. 7) Patients with collagen disease. 8) Pregnant, lactating, and probably pregnant patients, and patients who want to become pregnant during the study period. 9) Patients whose consent is not obtained from themselves in written form. 10) Other patients judged as being inappropriate for the subjects of the study by investigators.

Related Information


public contact
Name Hiroyuki Takano
Address Japan
Telephone 043-226-2701
Affiliation Chiba University Graduate School of Medicine Department of Cardiovascular Science and Medicine
scientific contact
Name Issei Komuro
Address 2-2, Yamada-oka, Suita, Osaka Japan
Affiliation Osaka University Graduate School of Medicine Department of Cardiovascular Medicine